BSX stock: buy or sell?
October 18th, 2019
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Should I buy BSX stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. That's why is so important to choose your own trading strategy that fits your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Boston Scientific stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Boston Scientific stock a buy?
Banks and financial institutions publish stock ratings everyday.At Stocks2.com, we detected 14 ratings published for BSX stock in the last month. The general sentiment of these ratings is bullish for BSX stock, with 11 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-9-5||JPMorgan Chase & Co.||n/a||Overweight|
|2019-6-27||Piper Jaffray Companies||n/a||Overweight|
|2019-6-27||Jefferies Financial Group||Buy||Positive|
|2019-6-18||Wells Fargo & Co||n/a||Outperform|
|2019-2-6||Needham & Company LLC||n/a||Buy|
|2019-1-8||Needham & Company LLC||n/a||Buy|
BSX stock analysis
Shares of Boston Scientific grew a tiny 0.79% and closed at $38.47.
Boston Scientific shares grew 0.79% to $38.47 on Oct/18. Since price and SMA200d lines crossed down on Oct/8, BSX fell $-1.88 per share (-4.66%).
After sliding a hair-raising -6.02% in a week last week, Boston Scientific closed this week at $38.47 and stepped up a slightly fine 0.63%.
Since last week, when BSX stock price broke down the 40-weeks moving avarage line, it slid $-2.06 per share (-5.08%). Trading stocks that are under the 40-weeks (that is, 200-days) moving average mark is not recommended by many experts, as it indicates that the stock has not enough institutional support.
BSX stock price history
BSX stock went public on May 19th, 1992 with a price of $4.251. Since then, BSX stock grew a 805.20%, with a yearly average of 29.80%. If you had invested $1,000 in BSX stock in 1992, it would worth $8,052.00 today.
1: Adjusted price after possible price splits or reverse-splits.
BSX stock historical price chart
BSX stock reached 52-week highs on September/6 at $43.84, and all-time highs 2004-04-06 with a price of 46.1.
BSX stock price target is $46.50Nobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we found 13 price predictions for BSX stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-7-25||Raymond James||Raises Target||$48.00||$50.00||4.2%|
|2019-6-27||Piper Jaffray Companies||Raises Target||$42.00||$50.00||19%|
|2019-6-27||Jefferies Financial Group||Raises Target||$44.00||$48.00||9.1%|
|2019-6-18||Wells Fargo & Co||Raises Target||$42.00||$45.00||7.1%|
|2019-2-6||Needham & Company LLC||Reiterates||n/a||$43.00||-|
|2019-1-8||Needham & Company LLC||Reiterates||n/a||$43.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn February, Boston Scientific presented its financial report, posting a slightly good growth for the Earnings per Share (EPS) ratio. Experts expected $0.37 per share, but Boston Scientific posted $0.39.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Boston Scientific annual revenues escalated a great 8.57% to $9,823.00 M dollars from $9,048.00 marked in 2017. In line, its income margin (compared to sales) boosted to 17.01%, that is $1,671.00 million.
|2013||$7,140 M||-||$-121.00 M-1.7%||-|
|2014||$7,380 M||3.36%||$-119.00 M-1.6%||-1.65%|
|2015||$7,477 M||1.31%||$-239.00 M-3.2%||100.84%|
|2016||$8,386 M||12.16%||$347 M4.1%||-245.19%|
|2017||$9,048 M||7.89%||$104 M1.1%||-70.03%|
|2018||$9,823 M||8.57%||$1,671 M17.0%||1,506.73%|
Quarterly financial resultsBoston Scientific posted $2,561.00 million in sales for 2018-Q4, a 7.02% up compared to previous quarter. Reported quarter income marked $386.00 million with a profit margin of 15.07%. Profit margin slightly fell a -2.98% compared to previous quarter when profit margin was 18.05%. When comparing revenues to same quarter last year, Boston Scientific sales marked a shining increase and rose a 6.35%.
|2017-Q2||$2,260 M||-||$146 M6.5%||-|
|2017-Q3||$2,220 M||-1.77%||$283 M12.7%||93.84%|
|2017-Q4||$2,408 M||8.47%||$-615 M-25.5%||-317.31%|
|2018-Q1||$2,379 M||-1.20%||$298 M12.5%||-148.46%|
|2018-Q2||$2,490 M||4.67%||$555 M22.3%||86.24%|
|2018-Q3||$2,393 M||-3.90%||$432 M18.1%||-22.16%|
|2018-Q4||$2,561 M||7.02%||$386 M15.1%||-10.65%|
|2019-Q1||$2,493 M||-2.66%||$424 M17.0%||9.84%|
Boston Scientific ownershipWhen you are planning to invest in shares of a company, it's worth to check its ownership structure.
Boston Scientific shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.25% of all shares.
Bearish positions for BSX stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Boston Scientific:
|Market cap||$53.5 B||$550.4 M||$2.8 B||$47.3 B||$144.9 B|
|Total shares||1,390.0 M||37.6 M||28.3 M||208.0 M||1,340.0 M|
|Float shares||1,390.0 M||37.1 M||27.6 M||206.5 M||1,340.0 M|
|- Institutional holdings (%)||93.4%||102.5%||97.5%||0.0%||84.2%|
|- Insider holdings (%)||0.2%||2.5%||1.8%||3.9%||0.1%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Friday, October 18th, 2019|
|Day range||$38.01 - $38.66|
|Average true range||$0.97|
|50d mov avg||$41.31|
|100d mov avg||$41.53|
|200d mov avg||$39.71|
Boston Scientific performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. In the following table, we compare Boston Scientific to AngioDynamics, CONMED, Edwards Lifesciences, Medtronic, Merit Medical Systems, Stryker and Teleflex:
|MMSIMerit Medical Sys...||-44.31%||-46.86%||-51.15%|
Boston Scientific competitorsWe picked a few stocks to conform a list of Boston Scientific competitors to examine if you are interested in investing in BSX:
- AngioDynamics (ANGO)
- CONMED (CNMD)
- Edwards Lifesciences (EW)
- Medtronic (MDT)
- Merit Medical Systems (MMSI)
- Stryker (SYK)
- Teleflex (TFX)
Latest BSX stock news
- Seeking AlphaBoston Scientific: A Diversified Portfolio With Growth ProspectsJuly 11, 2019
- InvestorPlace3 Big Stock Charts for Tuesday: Centene, Boston Scientific and Hewlett Packard EnterpriseMay 28, 2019
- Seeking AlphaBoston Scientific: New-Found Profitability After A Decade Of VolatilityMarch 22, 2019
- InvestorPlace3 Big Stock Charts for Thursday: FirstEnergy, Boston Scientific and MondelezFebruary 7, 2019
- InvestorPlace3 Stock Charts for Monday: Gap, CenterPoint Energy and Boston ScientificJanuary 7, 2019